642 related articles for article (PubMed ID: 23750683)
1. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence.
Persu A; Renkin J; Asayama K; O'Brien E; Staessen JA
Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):739-49. PubMed ID: 23750683
[TBL] [Abstract][Full Text] [Related]
2. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
[TBL] [Abstract][Full Text] [Related]
3. Renal denervation: unde venis et quo vadis?
Nähle CP; Düsing R; Schild H
Rofo; 2015 Apr; 187(4):237-47. PubMed ID: 25629384
[TBL] [Abstract][Full Text] [Related]
4. Renal denervation in moderate treatment-resistant hypertension.
Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
[TBL] [Abstract][Full Text] [Related]
5. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
[TBL] [Abstract][Full Text] [Related]
6. Renal denervation in the management of resistant hypertension: current evidence and perspectives.
Jin Y; Persu A; Staessen JA
Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):511-8. PubMed ID: 23892701
[TBL] [Abstract][Full Text] [Related]
7. Catheter-based renal denervation for treatment of resistant hypertension.
Vase H; Mathiassen ON; Kaltoft A; Pedersen EB; Christensen KL; Buus NH; Lederballe O; Lassen JF; Bøtker HE; Thuesen L
Dan Med J; 2012 Jun; 59(6):A4439. PubMed ID: 22677237
[TBL] [Abstract][Full Text] [Related]
8. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
[TBL] [Abstract][Full Text] [Related]
9. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS;
Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
[TBL] [Abstract][Full Text] [Related]
10. Renal Denervation After SYMPLICITY HTN-3: Where Do We Go?
Briasoulis A; Bakris G
Can J Cardiol; 2015 May; 31(5):642-8. PubMed ID: 25828371
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous renal sympathetic denervation: 2013 and beyond.
Froeschl M; Hadziomerovic A; Ruzicka M
Can J Cardiol; 2014 Jan; 30(1):64-74. PubMed ID: 24365191
[TBL] [Abstract][Full Text] [Related]
12. Updated ESH position paper on interventional therapy of resistant hypertension.
Schmieder RE; Redon J; Grassi G; Kjeldsen SE; Mancia G; Narkiewicz K; Parati G; Ruilope L; van de Borne P; Tsioufis C;
EuroIntervention; 2013 May; 9 Suppl R():R58-66. PubMed ID: 23732157
[TBL] [Abstract][Full Text] [Related]
13. [Renal denervation a new treatment option in resistant arterial hypertension].
Himmel F; Bode F; Schunkert H; Weil J
Praxis (Bern 1994); 2011 Nov; 100(22):1353-60. PubMed ID: 22048911
[TBL] [Abstract][Full Text] [Related]
14. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
Epstein M; de Marchena E
J Am Soc Hypertens; 2015 Feb; 9(2):140-9. PubMed ID: 25649995
[TBL] [Abstract][Full Text] [Related]
15. Renal sympathetic denervation in hypertension.
Doumas M; Faselis C; Papademetriou V
Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):647-53. PubMed ID: 21885968
[TBL] [Abstract][Full Text] [Related]
16. Expanding the indication spectrum: renal denervation in diabetes.
Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
[TBL] [Abstract][Full Text] [Related]
17. Transradial renal denervation for the treatment of resistant hypertension.
Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R
J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989
[TBL] [Abstract][Full Text] [Related]
18. Renal denervation for resistant hypertension and beyond.
Laffin LJ; Bakris GL
Adv Chronic Kidney Dis; 2015 Mar; 22(2):133-9. PubMed ID: 25704350
[TBL] [Abstract][Full Text] [Related]
19. [Interventional renal sympathetic denervation - a new approach for patients with resistant hypertension].
Mahfoud F; Böhm M
Dtsch Med Wochenschr; 2010 Dec; 135(48):2422-5. PubMed ID: 21108158
[TBL] [Abstract][Full Text] [Related]
20. Catheter-based radiofrequency renal-nerve ablation in patients with resistant hypertension.
Azizi M; Steichen O; Frank M; Bobrie G; Plouin PF; Sapoval M
Eur J Vasc Endovasc Surg; 2012 Mar; 43(3):293-9. PubMed ID: 22237510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
